ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ZCMD Zhongchao Inc

1.48
-0.12 (-7.50%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Zhongchao Inc NASDAQ:ZCMD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.12 -7.50% 1.48 1.48 1.51 1.64 1.48 1.64 71,262 00:59:58

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

13/01/2021 3:50pm

Edgar (US Regulatory)


 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of January 2021

 

ZHONGCHAO INC.

(Translation of Registrant's name into English)

 

Nanxi Creative Center, Suite 218

841 Yan’an Middle Road

Jing’An District, Shanghai, China 200040

Tel: 021-32205987

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒          Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 

 

 

 

CONTENTS

 

On January 13, 2021, Zhongchao Inc. (the “Company”) issued a press release announcing that it co-sponsored the National Annual Conference for Standardized Liver Cancer Diagnosis and Treatment with China Association of Health Promotion and Education and Chinese Society of Liver Cancer.

 

A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

 

Financial Statements and Exhibits.

 

Exhibit   Description
99.1   Press release dated January 13, 2021.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  Zhongchao Inc.
     
  By: /s/ Weiguang Yang 
  Name: 

Weiguang Yang

Chief Executive Officer

  Title: 

 

Date: January 13, 2021

 

 

2

 

 

1 Year Zhongchao Chart

1 Year Zhongchao Chart

1 Month Zhongchao Chart

1 Month Zhongchao Chart

Your Recent History

Delayed Upgrade Clock